Bruce IN - Search Results

1

Rheumatoid arthritis association at 6q23.

Thomson W, Barton A, Ke X, Eyre S, Hinks A, Bowes J, Donn R, Symmons D, Hider S, Bruce IN; Wellcome Trust Case Control Consortium; Wilson AG, Marinou I, Morgan A, Emery P; YEAR Consortium; Carter A, Steer S, Hocking L, Reid DM, Wordsworth P, Harrison P, Strachan D, Worthington J. Thomson W, et al. Among authors: bruce in. Nat Genet. 2007 Dec;39(12):1431-3. doi: 10.1038/ng.2007.32. Epub 2007 Nov 4. Nat Genet. 2007. PMID: 17982455 Free PMC article.

2

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.

Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF, Symmons DPM; TRACE RA Consortium. Kitas GD, et al. Arthritis Rheumatol. 2019 Sep;71(9):1437-1449. doi: 10.1002/art.40892. Epub 2019 Jul 22. Arthritis Rheumatol. 2019. PMID: 30983166 Free PMC article. Clinical Trial.

3

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

Chadwick L, Kearsley-Fleet L, Brown N; BSRBR-RA Control Centre consortium; BSRBR-RA Contributors Group; Watson KD, Lunt M, Symmons DPM, Hyrich KL. Chadwick L, et al. Rheumatology (Oxford). 2020 Mar 1;59(3):559-567. doi: 10.1093/rheumatology/kez277. Rheumatology (Oxford). 2020. PMID: 31722431

4

Comprehensive genetic and functional analyses of Fc gamma receptors influence on response to rituximab therapy for autoimmunity.

Robinson JI, Md Yusof MY, Davies V, Wild D, Morgan M, Taylor JC, El-Sherbiny Y, Morris DL, Liu L, Rawstron AC, Buch MH, Plant D, Cordell HJ, Isaacs JD, Bruce IN, Emery P, Barton A, Vyse TJ, Barrett JH, Vital EM, Morgan AW; MATURA Consortia; MASTERPLANS Consortia. Robinson JI, et al. Among authors: bruce in. EBioMedicine. 2022 Dec;86:104343. doi: 10.1016/j.ebiom.2022.104343. Epub 2022 Nov 11. EBioMedicine. 2022. PMID: 36371989 Free PMC article.

5

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients.

Hamann PDH, Pauling JD, McHugh N, Shaddick G, Hyrich K; BSRBR-RA Contributors Group. Hamann PDH, et al. Rheumatology (Oxford). 2019 Dec 1;58(12):2162-2169. doi: 10.1093/rheumatology/kez188. Rheumatology (Oxford). 2019. PMID: 31155669 Free PMC article.

6

Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial.

Verstappen SM, McCoy MJ, Roberts C, Dale NE, Hassell AB, Symmons DP; STIVEA investigators. Verstappen SM, et al. Ann Rheum Dis. 2010 Mar;69(3):503-9. doi: 10.1136/ard.2009.119149. Epub 2009 Oct 12. Ann Rheum Dis. 2010. PMID: 19825849 Clinical Trial.

7

Can the General Public Be a Proxy for an "At-Risk" Group in a Patient Preference Study? A Disease Prevention Example in Rheumatoid Arthritis.

DiSantostefano RL, Simons G, Englbrecht M, Humphreys JH, Bruce IN, Bywall KS, Radawski C, Raza K, Falahee M, Veldwijk J. DiSantostefano RL, et al. Among authors: bruce in. Med Decis Making. 2024 Feb;44(2):189-202. doi: 10.1177/0272989X231218265. Epub 2024 Jan 19. Med Decis Making. 2024. PMID: 38240281 Free PMC article.

8

Psoriatic arthritis: the role of self-reported non-adherence, non-trough drug levels, immunogenicity and conventional synthetic DMARD co-therapy in adalimumab and etanercept response.

Curry PDK, Morris AP, Jani M, Chinoy H, Barton A, Bluett J; OUTPASS Collaborators. Curry PDK, et al. Rheumatol Adv Pract. 2024 Jan 30;8(1):rkae014. doi: 10.1093/rap/rkae014. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38415954 Free PMC article.

9

The influence of deprivation in the outcomes of psoriatic arthritis within the UK-utilizing Outcomes of Treatment in Psoriatic Arthritis Study Syndicate (OUTPASS) data.

Lyon M, Zhao SS, Jani M, Chinoy H, Barton A, Bluett J; OUTPASS Study Syndicate. Lyon M, et al. Rheumatol Adv Pract. 2024 May 2;8(2):rkae051. doi: 10.1093/rap/rkae051. eCollection 2024. Rheumatol Adv Pract. 2024. PMID: 38721964 Free PMC article. No abstract available.

10

An imperfect world: assessing safety of biological treatments in systemic lupus erythematosus. Comment on the article by Materne et al.

Rodziewicz M, Dyball S, Achieng S, Brix SR, Parker B, Bruce IN. Rodziewicz M, et al. Among authors: bruce in. Arthritis Rheumatol. 2024 Feb;76(2):315-316. doi: 10.1002/art.42689. Epub 2023 Oct 30. Arthritis Rheumatol. 2024. PMID: 37653671 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters